TY - JOUR
T1 - Prior immunization against an intracellular antigen enhances subsequent red blood cell alloimmunization in mice
AU - Jajosky, Ryan
AU - Patel, Seema R.
AU - Wu, Shang Chuen
AU - Patel, Kashyap
AU - Covington, Mischa
AU - Vallecillo-Zúniga, Mary
AU - Ayona, Diyoly
AU - Bennett, Ashley
AU - Luckey, C. John
AU - Hudson, Krystalyn E.
AU - Hendrickson, Jeanne E.
AU - Eisenbarth, Stephanie C.
AU - Josephson, Cassandra D.
AU - Zerra, Patricia E.
AU - Stowell, Sean R.
AU - Arthur, Connie M.
N1 - Funding Information:
This work was partially supported by the Burroughs Wellcome Trust Career Award for Medical Scientists, the National Institutes of Health National Heart, Lung, and Blood Institute (NHLBI) R01 HL165975 and HL135575 (S.R.S.), NHLBI R01 HL154034 (C.M.A.), and NHLBI R01 HL132951 (J.E.H.), and NHLBI Institutional Training Grant 5K12HL141953-05 (R.J.). This research project was partially supported by the Emory University Integrated Cellular Imaging Core .
Publisher Copyright:
© 2023 The American Society of Hematology
PY - 2023/5/25
Y1 - 2023/5/25
N2 - Antibodies against red blood cell (RBC) alloantigens can increase morbidity and mortality among transfusion recipients. However, alloimmunization rates can vary dramatically, as some patients never generate alloantibodies after transfusion, whereas others not only become alloimmunized but may also be prone to generating additional alloantibodies after subsequent transfusion. Previous studies suggested that CD4 T–cell responses that drive alloantibody formation recognize the same alloantigen engaged by B cells. However, because RBCs express numerous antigens, both internally and externally, it is possible that CD4 T–cell responses directed against intracellular antigens may facilitate subsequent alloimmunization against a surface RBC antigen. Here, we show that B cells can acquire intracellular antigens from RBCs. Using a mouse model of donor RBCs expressing 2 distinct alloantigens, we demonstrate that immune priming to an intracellular antigen, which would not be detected by any currently used RBC compatibility assays, can directly influence alloantibody formation after exposure to a subsequent distinct surface RBC alloantigen. These findings suggest a previously underappreciated mechanism whereby transfusion recipient responders may exhibit an increased rate of alloimmunization because of prior immune priming toward intracellular antigens.
AB - Antibodies against red blood cell (RBC) alloantigens can increase morbidity and mortality among transfusion recipients. However, alloimmunization rates can vary dramatically, as some patients never generate alloantibodies after transfusion, whereas others not only become alloimmunized but may also be prone to generating additional alloantibodies after subsequent transfusion. Previous studies suggested that CD4 T–cell responses that drive alloantibody formation recognize the same alloantigen engaged by B cells. However, because RBCs express numerous antigens, both internally and externally, it is possible that CD4 T–cell responses directed against intracellular antigens may facilitate subsequent alloimmunization against a surface RBC antigen. Here, we show that B cells can acquire intracellular antigens from RBCs. Using a mouse model of donor RBCs expressing 2 distinct alloantigens, we demonstrate that immune priming to an intracellular antigen, which would not be detected by any currently used RBC compatibility assays, can directly influence alloantibody formation after exposure to a subsequent distinct surface RBC alloantigen. These findings suggest a previously underappreciated mechanism whereby transfusion recipient responders may exhibit an increased rate of alloimmunization because of prior immune priming toward intracellular antigens.
UR - http://www.scopus.com/inward/record.url?scp=85153583755&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85153583755&partnerID=8YFLogxK
U2 - 10.1182/blood.2022016588
DO - 10.1182/blood.2022016588
M3 - Article
C2 - 36638335
AN - SCOPUS:85153583755
SN - 0006-4971
VL - 141
SP - 2642
EP - 2653
JO - Blood
JF - Blood
IS - 21
ER -